Lindsay Flora

Lindsey-Flora

Lindsay Flora

Partner

New York | Three Bryant Park, 1095 Avenue of the Americas, New York, NY, United States of America 10036-6797
+1 212 649 8798 | +1 212 698 3599

| vCard | PDF

Lindsay Flora advises clients on complex corporate transactions and high yield financings, including leveraged acquisitions, syndicated debt facilities, debt commitments, bridging loans and secured lending. Ms. Flora’s clients include leading private equity sponsors and firms, financial institutions, borrowers, lenders and private and public companies. In addition, she provides counsel on a broad range of general financial and corporate matters.

Prior to joining Dechert, Ms. Flora was a corporate partner at another international law firm. 

Experience
  • Cerberus in connection with its acquisition of Sparton Corporation.
  • Trilantic North America in connection with its acquisitions of OrthoLite and Asset Plus.
  • Sycamore Partners in its US$6.9 billion acquisition of Staples, Inc.
  • Monomoy Capital Partners on the financing for their acquisition of West Marine, Inc.
  • Klöckner Pentaplast of America, Inc., a portfolio company of Strategic Value Partners, in connection with the financing for its acquisition of LINPAC.
  • Advent International on the financing for its acquisition of CCC Information Services, Inc.
  • Altor and Goldman Sachs Merchant Banking on the refinancing for Navico. 
  • Coca-Cola Enterprises in its combination with Coca-Cola Iberian Partners and Coca-Cola Erfrischungsgetränkt to create a newly formed entity, Coca-Cola European Partners plc.
  • Lead arrangers in connection with term and revolving financing for Ancestry.com, the world’s largest online history resource.
  • Lorillard, Inc. in its acquisition of the assets of BLU electronic cigarettes.
  • Elan Corp. plc in connection with the approximately US$960 million sale of Elan Drug Technologies to Alkermes, Inc.
  • Underwriters, initial purchasers and lead arrangers in connection with the secured and unsecured debt financings and equity financings for Envision Healthcare, including its Initial Public Offering of 48,300,000 shares of common stock of Envision Healthcare Holdings, Inc. resulting in gross proceeds of US$1,110,900,000.
  • Underwriters, initial purchasers and lead arrangers in connection with the secured and unsecured debt financings and equity financings for Berry Plastics Corporation.
  • Financing sources in their various capacities as initial purchasers, underwriters, agents and lead arrangers in over US$16 billion in debt, equity and bank financing transactions that backed the acquisition of Salix Pharmaceuticals by Valeant Pharmaceuticals.
  • Underwriters, initial purchasers and lead arrangers in connection with the secured and unsecured debt financings and equity financings for HCA, Inc.
  • Underwriters, initial purchasers and lead arrangers in connection with the secured and unsecured debt financings for Omnicare. 
  • Dealer Managers in a US$2.8 billion exchange offer by California Resources Corporation.
  • Gaming and Leisure Properties in its $1.375 billion senior notes offering.
  • Financing sources in connection with the Rule 144A offering of US$950 million senior secured notes and US$2.2 billion senior unsecured notes, issued by by Scientific Games International, Inc. relating to Scientific Games’ acquisition of Bally’s Technologies, Inc.
  • Underwriters, initial purchasers and lead arrangers in connection with the secured and unsecured debt financings and equity financings for 21st Century Fox.

Includes matters handled at Dechert or prior to joining the firm.

Education
  • American University, B.A., 2005, summa cum laude
  • New York Law School, J.D., 2008, magna cum laude, Executive Articles Editor, New York Law School Review, Moot Court Association, Harlan Scholars Honor Program
Admissions
  • New York